Economic Burden of Non-Alcoholic Steatohepatitis (NASH) Among Diabetic Population in Italy: Analysis and Perspectives.

Enrico TorreSergio Di MatteoGiacomo Matteo Bruno Chiara Martinotti Maria Chiara ValentinoGianni TestinoAlberto ReboraLuigi Carlo BottaroGiorgio Lorenzo Colombo

Published in: ClinicoEconomics and outcomes research : CEOR (2022)

Patients with NASH and T2DM reported an important burden in Italy. It is important to investigate the potential clinical and economic benefits of antidiabetic drugs that have been shown to be effective in preventing the transition to advanced disease, simultaneously acting on the therapeutic goals of diabetic disease.

Keyphrases

type diabetes
wound healing
risk factors
metabolic syndrome
adipose tissue